JPRN-UMIN000012269招募中未知
Effects of Eldecalcitol and/or Raloxifene on insulin sensitivity and carotid intima-media thickness in postmenopausal woman. - Effects of Eldecalcitol and/or Raloxifene on insulin sensitivity and carotid intima-media thickness in postmenopausal woman.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •The following subjects will be excluded from the study: 1.Pregnants women, women suspected of being pregnant, or lactating women 2.Patients who have been diagnosed or history of thromboembolism (including deep vein thrombosis, pulmonary embolism, retinal vein occlusion) 3.Patients who is a long term and immovable 4.Patients who is an antiphospholipid syndrome 5.Patients who have a hypersensitivity to Raloxifene or Eldecalcidol 6.Patients who are treated with bisphosphonates, or within 3 month after the suspension of administration 7.Patients whom the principle investigators or other investigators consider unsuitable
研究者
相似试验
招募中
不适用
Effects of Eldecalcitol and Raloxifene on the suppression of new vertebral fracture with osteoporosis in perimenopausal women or ovariectomy patients: Randomized controlled trialosteoporosis in perimenopausal women or ovariectomy patientsJPRN-UMIN000009378Tokyo Women's Medical University Hospital360
招募中
不适用
Effect of Eldcalcitol/ Raloxifene combination therapy for fall prevention in primary osteoporosis patients: a randomized controlled study.osteoporosisJPRN-UMIN000008216igata Rehabilitation Hospital100
已完成
不适用
Impact of raloxifene, eldecalcitol and their combination therapy on bone indices in postmenopausal subjects with osteoporosis and chronic kidney disease stage 3: Re Bone StudyJPRN-UMIN000018296Osaka City University Graduate School of Medicine
招募中
3 期
The effect of inositol on the improvement of primary sclerosing cholangitis patientsIRCT20220417054557N2Shahid Beheshti University of Medical Sciences40
招募中
不适用
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000043068Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine30